Abstract

Citation: Kartar AA, Horinouchi T, Örzsik B, Anderson B, Hall L, Bailey D, et al. (2025) Neurobiological substrates of altered states of consciousness induced by high ventilation breathwork accompanied by music. PLoS One 20(8):
e0329411.

https://doi.org/10.1371/journal.pone.0329411

Editor: Gaëtan Merlhiot, Institut VEDECOM, FRANCE

Received: August 6, 2024; Accepted: July 16, 2025; Published: August 27, 2025

Copyright: © 2025 Kartar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data for this study are publicly available from the OSF repository (https://doi.org/10.17605/OSF.IO/5WR9Q).

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

Introduction

High ventilation breathwork (HVB) encompasses contemplative and therapeutic practices, including Conscious Connected Breathing or Holotropic Breathwork, in which a controlled pattern of volitional breathing increases the rate or depth of ventilation and is typically accompanied by evocative music. Despite their distinct historical roots and delivery modalities, these different HVB practices share a purported ability to elicit acute extraordinary alterations in subjective experience that closely resemble the qualia of altered states of consciousness (ASCs) induced by psychedelic substances [1–3]. Converging evidence demonstrates the potential value of psychedelic treatments for specific difficult-to-treat psychiatric and physiological conditions [4–7]. The induction of ASCs is suggested to be critical to the therapeutic action of psychedelic substances [8–10], for which HVB might therefore offer a non-pharmacological alternative, with fewer legal and ethical restrictions to large-scale adoption in clinical treatment. In line with this, the popularity of HVB as a therapeutic tool for psychological distress is rapidly expanding, indexed by an increased number of scientific investigations, see [11,12] for more details.

The therapeutic potential of HVB practices is suggested by a long cultural tradition of use to relieve symptoms of psychological distress [11,13] and by emerging preliminary evidence of clinical efficacy from controlled trials in affective and trauma-related disorders [14]. Prolonged hyperventilation/HVB reportedly elicits a wide range of effects on subjective experience that include emotional and psychedelic-like phenomena (ASCs), which range from panic-like sensations to feelings of awe and dissociative symptoms [11]. The 5D-ASC questionnaire is popularly used in ASC research to retrospectively assess such states [15]. A key dimension of this scale is ‘Oceanic Boundlessness’ (OBN); a term coined by Freud in 1920 [16] which describes a set of related feelings including ‘spiritual experience, insightfulness, blissful state, positively experienced depersonalization, and the experience of unity’ [17]. OBN is considered as a defining aspect of ASCs evoked by psychedelic substances, such as psilocybin. However, the neurobiological mechanisms and subjective experience underlying ASCs induced by HVB have not been studied extensively and remain elusive.

First, we characterised the subjective experience of HVB to capture the nature and intensity of evoked experiential phenomena. From these data, we aimed to assess whether these effects could be reliably reproduced in controlled experimental settings in comparison to a remote – and more ecologically valid – condition. These findings informed the choice of the ASC variable, OBN, which was ultimately selected as the most widely reported experiential phenomena to identify the critical neurobiological effects of HVB.

Then we examined the effects of HVB performed by experienced breathwork practitioners in different experimental settings, and investigated peripheral and central neurophysiological mechanisms underpinning ASCs engendered by HVB. The neurobiological endpoints were selected based on well-characterised neurophysiological effects of hyperventilation (reviewed in [11]). Hyperventilation acutely reduces regional cerebral blood flow (rCBF) through interacting effects of hypocapnia, cerebral alkalosis and hypoxia, resulting in transient perturbation of neurometabolic homeostasis. Further, hyperventilation evokes allostatic changes in action-ready bodily arousal, mediated via the autonomic nervous system via the dominance of sympathetic over parasympathetic drive to the heart and blood vessels. In characterising the neurobiological effects of HVB and associated ASCs, we therefore focused our measurements on two robust indices of neurometabolic and autonomic nervous control: rCBF and heart rate variability (HRV).

To our knowledge, no studies have previously reported the relationship between the intensity of ASCs and changes in rCBF induced by HVB practices. Since we could not base our prediction of the regional specificity of such correlations on previous knowledge, we preferred to adopt a whole brain voxelwise exploratory approach. Also, as observations reported on the effects of psychedelics on autonomic nervous system activity have been contrasting [18,19], we could not make precise predictions on the direction of association between HRV and ASCs.

Our study was designed to address different objectives through three inter-related experiments: (please see the methods for more details), in 1) HVB was conducted over an online video-conferencing platform with a breathwork facilitator (REMOTE setting). The aim was to characterise the subjective response to remote HVB in a home setting, and inform the choice of the ASC domain to be used as subjective endpoint. In 2), we used pseudo-continuous arterial spin labelling (pCASL) magnetic resonance imaging (MRI) of the brain during HVB to identify the relationship between neural haemodynamic effects of HVB and subjective measures (MRI setting). In 3) HVB was performed in a psychophysiology lab to characterise the relationship between the psychophysiological effects of HVB (autonomic alterations, see ‘psychophysiological session 3’ for more information) and subjective measures (LAB setting).

Materials and methods

Results

Self-reported data from 42 participants were analysed, comprising 31 unique individuals. Study participants enrolled in one to three experimental sessions: n = 15 (age 42.9 ± 12.6 years, 5 females) for the online experimental session; n = 8 (age 41 ± 13.02 years, 2 females) for the session conducted within the psychophysiology lab; and n = 19 (age 43.7 ± 11.9; 7 females) for the MRI experimental session. There were different participants in each condition (3 repeated all conditions, 5 participants participated in 2 conditions, see S1 Fig for key subjective effects of repeated participants). No adverse events, including panic attacks, were reported across all experimental settings.

Discussion

Our study is the first that aims to characterise the relationship between the intensity of ASCs induced by HVB practices and associated central and autonomic nervous system effects, via changes in pcASL rCBF and HRV, respectively. Our findings identified significant correlations that might indicate possible neurobiological substrates of HVB-evoked ASCs, accompanied by music. First, our findings demonstrated that the experience of HVB can be safely reproduced across different experimental settings. The pattern of self-reported experiences elicited within the MRI scanner and psychophysiology lab were analogous to those experienced at home (a more natural and comfortable environment).

During all experimental sessions, participants reported a trend-level reduction in ratings of fear and negative emotions. Additionally, no adverse reactions or panic attacks were experienced by any participants. However, there was a mild increase in discomfort ratings and mild panic-like symptoms were reported during the MRI session – although these were not associated to increased anxiety or panic attacks and might have been evoked by the physical constraints of being inside the MRI chamber. This experience conflicts typical breathwork practice. The observed increase in physical discomfort alongside reductions in fear and negative affect may reflect a hormetic effect, whereby transient physiological or emotional stressors promote longer-term psychological resilience [35,36].

Across participants and experimental settings, HVB reliably enhanced ASCs dominated by OBN, which is considered as a defining aspect of ASCs evoked by psychedelic substances, such as psilocybin. Although differences in OBN scores across conditions were not statistically significant, participants in the LAB condition reported noticeably higher scores compared to MRI and REMOTE sessions. This trend suggests that the in-person experience and controlled, quiet environment of the LAB may have enhanced the immersive and evocative qualities of the breathwork experience. In contrast, the MRI setting—despite also involving in-person contact —may have been less conducive due to scanner noise and physical constraints. Finally, the REMOTE condition, which involved no in-person interaction and took place in participants varied home environments, received the lowest OBN ratings. These findings point to the importance of ‘set and setting’, e.g., [37], a concept well-established in psychedelic research in shaping ASCs and subjective response. These results may indicate that physical context and interpersonal presence play a critical role in breathwork outcomes.

Interestingly, OBN is reportedly the most accurate predictor of antidepressant actions of psychedelic substances [9,38–40]. In the present study, the magnitude of the OBN experience induced by HVB was comparable to that elicited by serotonergic psychedelic substances, including psilocybin and lysergic acid diethylamide (LSD) [41,42], reinforcing observations of other breathwork studies [1,2].

Fast-paced hyperventilation induces cardiovascular sympathetic activation (with relative cardiovagal parasympathetic withdrawal) and cerebral vasoconstriction, the latter is a consequence of respiratory alkalosis, resulting from reduced plasma CO₂ and H⁺, which elevates blood pH [43]. Ergo, we focused our analysis on correlations between OBN and changes in HRV (for which decreases capture pro-sympathetic shifts in cardiac autonomic balance) and CBF (where regional reductions reflect cerebrovascular vasoconstriction). Importantly, decreased EtCO₂ is implicated as a critical factor in catalysing stronger, deeper ASCs during breathwork and may predict subacute psychological and physiological outcomes [2,44].

Our experiments identified that HVB engendered substantive time-dependent decreases in pcASL CBF. The reduction of rCBF relative to BASELINE in a cluster localized within left posterior insula and left parietal operculum predicted the intensity of OBN. This region encompasses primary interoceptive cortex and represents the state of cardiorespiratory arousal, and is consequently engaged in higher-order respiratory control. Correspondingly, neural activity here is enhanced by chemo-stimulated increases in ventilation [45]. More broadly, this insular-parietal region supports the integration of somatosensory information as well as the cortical representation of afferent respiratory and bodily signals [46], for example in the emergence of conscious motor intentions [47]. It is also implicated in high-level integrative processes which merge external and internal stimuli [48,49] that contribute to a coherent, embodied representation of self [50].

These roles are relevant to the interpretations of our finding that rCBF reductions within the PO/INS during SUSTAINED HVB predicted the intensity of self-reported OBN experience. The construct of OBN is closely related to feelings of depersonalization, sense of unity and blissful state [16], and our findings align with the notion that abnormal integration of signals in the posterior insula cortex can result in abnormal body ownership. Studies on ecstatic epilepsy, a rare focal epilepsy, show that the insula is involved in ASC-like experiences, including “heightened self-awareness, mental clarity and unity with everything that exists, accompanied by a sense of bliss and physical well-being” [51]. These overlap with the OBN construct, as assessed in the 5D-ASC [15]. Picard and Craig [52] hypothesised the involvement of the insula in the genesis of ecstatic epilepsy given its role in interoception and self-consciousness, confirmed by intracerebral electrode recordings [53]. Seizures in the mesiotemporal region propagated to the dorsal anterior insula coincide with ecstatic symptoms [54] and stimulation of the mid-dorsal insula region evoked experiences akin to oceanic psychedelic effects [55]. The interruption of interoceptive predictive coding during anterior insula seizures may underlie the ecstatic experience, emphasizing its pivotal role in mystical and psychedelic states [51,52].

We then ran an exploratory subsequent analysis (Fig 5) to explore the correlations between sub-dimensions of the 11D-ASC relevant to OBN [17], namely ‘disembodiment’, ‘unity’ and ‘bliss’, and CBF reductions induced by HVB relative to BASELINE. We found that scores of ‘unity’ and ‘bliss’, but not ‘disembodiment’ were associated with CBF reductions (see S1–S3 Tables for details), which concurs with the notion discussed above, specifically pointing to an involvement of the insula in the genesis of blissful feelings. Of note, 5-HT2A– targeting compounds such as psilocybin, renowned for therapeutic utility, are known to induce CBF decreases in different brain regions that correlate with the intensity of psychedelic experiences [56]. Studies found reduced CBF in the insula following psilocybin administration, though it was not linked to the subjective effects assessed via the 5D-ASC [57].

CBF reductions occur rapidly following decreased EtCO₂ and can be reliably detected in response to very brief periods of hyperventilation. Conversely, the profound experiential changes in emotion and thought processes tend to emerge gradually, and correspondingly psychedelic phenomenology appears contingent on the length of the breathwork session [58]. Our investigation therefore compared HVB-evoked effects during late (SUSTAINED) and early (START) phases of HVB to focus specifically on the haemodynamic changes that occurred once the subjective effects had emerged. By contrasting the START and SUSTAINED phases of hyperventilation, we identified a region of right amygdala/anterior hippocampus, where the intensity of subjective experience (OBN as a covariate) positively correlated with CBF changes. Here, increased rCBF predicted the most intense OBN experience, despite the global reduction in CBF. One possible explanation is that this amygdalo-hippocampal CBF increase reflected increased regional neural activation associated with emergent expression of intense subjective effects. These regions are well established as being specialized for emotion (amygdala) and memory (hippocampus) processing. Their reciprocal interactions enable the formation of episodic representations, integrating the emotional significance and interpretation of memories [59]. Interestingly, increased right amygdala blood-oxygen level-dependent responses to emotional faces in functional MRI (fMRI) have been identified in patients with treatment-resistant depression following administration of psilocybin, predictive of clinical improvements at 1 week. The authors posit that this indicates psilocybin aids individuals’ ability to confront, reappraise, and improve emotional responsiveness [60]. Though speculative, these findings may indicate that HVB facilitates the processing of emotionally salient memories, which is proposed to be an essential therapeutic element in psychedelic-assisted psychotherapies [61,62], consistent with promising results from clinical trials of HVB applied as a therapy for patients with post-traumatic stress disorder (PTSD) [63]. Our finding of increased CBF in the hippocampal region also indicates that a single session of intense hyperventilation selectively alters perfusion to the hippocampus, similar to the effects observed after 20 minutes of hypocapnia-inducing moderate exercise [64]. This finding was interpreted as indicative of short-term metabolic adaptation to the high energy demands of hippocampal neurons, rather than reflecting the effects of mechanical vascular changes [64].

HRV is a physiological index of the balance of sympathetic and parasympathetic influences on the heart. The observed reduction in HRV reflects sympathetic activation and withdrawal of parasympathetic drive [65–67], consistent with an action-ready state of psychophysiological engagement. As previously described, OBN characteristically entails a deeply felt positive mood linked to the experience of unity with the self and the world, and in its extreme, is experienced as a mystical or religious experience [17]. Our finding that OBN ratings were related to changes in HRV over time echoes observations from other relevant modalities of ASC induction, such as self-induced cognitive trance [68] or 5-HT agonists, such as LSD [18,69–71] or N,N-Dimethyltryptamine (DMT) [72,73]. Nevertheless, the observed association with a positive mood contrasts the wide acceptance of reduced HRV as an index of stress and negative affective states. During HVB, the physiological state of the body exceeds typical homeostatic boundaries, and the autonomic correlates of this may reinforce a dissociative psychological state of positive affect in line with the premise of hormesis, see [11] for more.

This exploratory work is preliminary and limited by a small sample size and a lack of an independent control condition that may, in our neuroimaging session, have prevented us from separating the contributions of haemodynamic effects secondary to CO₂ changes from neural activation. We also acknowledge the possibility that our whole brain voxelwise approach has led to reduced sensitivity to detect significant correlations relative to an a priori region of interest (ROI) approach. In addition, from a methodological perspective, it may be argued that the lack of control group exposed only to music may prevent dissociation of the effects of auditory stimuli (the ambient track) and the effects of HVB. Listening to upbeat music does stimulate ventilation and this should be controlled in the future. Helpful input from lived experience populations indicates that music is a powerful support to therapeutic applications of HVB. In choosing our design, we elected not to “dissect” the music component from HVB, as we preferred to consider HVB as a contemplative practice accompanied by music as a whole – and to test it in its entirety [74]. Importantly, both studies [2,75] have dissected the effect of music and breathwork, and elucidate that music is not the main factor in triggering ASCs. This reveals that music alone is unlikely to engender significant ASCs of the magnitude reported in this research. It is also argued that the reductionist approach of breaking down a contemplative practice to dissect an “active ingredient” is less preferable than testing a practice in its entirety [74]. Conjointly, psychedelic therapy sessions do not adhere to one specific psychotherapeutic model, though one consistent feature of the experience is listening to music. During psychedelic therapy sessions, patients are urged to centre their attention inwardly whilst supine and listening to a carefully selected playlist. It is suggested that music can help facilitate therapeutic experiences. As such, we are looking for CBF changes that correspond with ASCs, induced by HVB with music. We elected to proceed to treat the experience as whole, hence no control for music. More hypothesis-driven work is certainly required within the neuroscience of breathwork.

Furthermore, our study focused on experienced HVB practitioners and therefore our results may not be generalisable; though this is also a strength as it ensured our practitioners were able to reach the desired state without adverse outcomes. Additionally, we were unable to directly assess relevant mechanisms of therapeutic actions, as our subjective measures did not include clinical parameters relevant to traumatic memories or other forms of psychological distress. Moreover, ASCs initiated by breathwork are inherently dynamic, thus dynamic phenomenological tools, such as those employed by Lewis-Healey et al., [58] may be more sensitive and informative.

Our imaging approach was also limited by the absence of correction for physiological noise caused by cardiac and respiratory fluctuations. This is crucial for most physiological fMRI applications for reducing signal artifacts. However, physiological fluctuations (including respiratory frequency and volume changes) can still introduce signal variations in ASL data, but we believe that our approach remains robust. Our analysis inherently averages over multiple cardiac cycles, which helps mitigate the effects of physiological noise on CBF quantification, and although respiration-induced signal changes are observed in some pcASL studies, they are largely associated with motion rather than direct vascular effects [76]. This does not fully eliminate the influence of an overall increase in HR, respiratory rate, or other physiological parameters during changes in breathing conditions—factors that may also impact labelling efficiency and arterial transit times. These considerations are relevant not only to our study, but to other ASL studies where complex, interconnected factors can influence ASL signal and CBF. Practical constraints limit the extent to which additional physiological measurements can be incorporated, particularly in a study as complex as ours. These constraints include scanning time and the potential stress on participants. Furthermore, measuring CBF at the start of the SUSTAINED HVB rather than at the end or during is not ideal, yet, it may capture the physiological ‘trigger condition’ for entry into ASCs, which can continue irrespective of specific physiological threshold conditions, see [2] for more.

A further key reason for choosing not to adopt a method of correction for EtCO₂ was a high risk of regressing out our primary signal of interest. One plausible mechanistic hypothesis inspiring our work is that ASCs evoked by HVB practices directly result from alterations in EtCO₂ and the resulting cerebral pH, causing downstream effects on neuronal function [11]. Therefore, CO₂ related physiological signals are likely correlated with experimental effects that were the focus of our investigation, in line with recent work by others [2] and regressing out these signals would severely impact our sensitivity to study the relationship between haemodynamic effects and ASCs. An additional reason is that our measures of EtCO₂ (collected by nasal cannula and capnograph) have been occasionally incomplete during the end of HVB sessions when EtCO₂ levels had reached particularly low levels, and we felt that application of correction methods using incomplete physiological data would have risked introducing major artifacts.

Additionally, we observed prominent arterial transit time (ATT) artifacts in 6 out of 19 participants. These artifacts were characterized by strong arterial signals in the CBF images, which led to their exclusion from the analysis. ATT artifacts can significantly impact the accuracy of perfusion measurements, as they indicate that labelled blood has not yet reached the capillary beds. To address this issue in future research, capturing blood flow dynamics at different delay times through a multi-PLD ASL protocol would reduce the impact of ATT artifacts and increase precision of assessment of cerebral perfusion.

Conclusion

In conclusion, our exploratory experiments suggest that circuitries supporting the integration of interoceptive representations and processing of affective memories are putative neurobiological substrates of HVB-induced ASCs. Our findings indicate directions for future research towards a better understanding of HVB and ultimately harnessing such practices for future therapeutic applications.

Supporting information

Acknowledgments

The authors wish to acknowledge Dr Guy Fincham, Dr Matthew Wall, and Dr Natalie Ertl for their helpful contribution, and all the participants for their expert insights into breathwork.

References

1. 1.
   Bahi C, Irrmischer M, Franken K, Fejer G, Schlenker A, Deijen JB, et al. Effects of conscious connected breathing on cortical brain activity, mood and state of consciousness in healthy adults. Curr Psychol. 2023;43(12):10578–89.
   • 
     View Article
     
   • 
     Google Scholar
     
2. 2.
   Havenith MN, Leidenberger M, Brasanac J, Corvacho M, Carmo Figueiredo I, Schwarz L, et al. Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness. Commun Psychol. 2025;3(1):59. pmid:40223145
   • 
     View Article
     
   • 
     PubMed/NCBI
     
   • 
     Google Scholar
     
3. 3.
   Eyerman J. A clinical report of Holotropic Breathwork in 11,000 psychiatric inpatients in a community hospital setting. Multidiscip Assoc Psychedelic Stud Bulletin Special Ed. 2013;23(1):24–7.
   • 
     View Article
     
   • 
     Google Scholar
     
4. 4.
   Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R. Trial of psilocybin versus escitalopram for depression. New England J Med. 2021;384(15):1402–11.
   • 
     View Article
     
   • 
     Google Scholar
     
5. 5.
   Zeifman RJ, Palhano-Fontes F, Hallak J, Arcoverde E, Maia-Oliveira JP, Araujo DB. The impact of ayahuasca on suicidality: results from a randomized controlled trial. Front Pharmacol. 2019;10.
   • 
     View Article
     
   • 
     Google Scholar
     
6. 6.
   Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, et al. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv. 2021;7(47):eabh2399. pmid:34788104
   • 
     View Article
     
   • 
     PubMed/NCBI
     
   • 
     Google Scholar
     
7. 7.
   Almahayni O, Hammond L. Does the Wim Hof Method have a beneficial impact on physiological and psychological outcomes in healthy and non-healthy participants? A systematic review. PLoS One. 2024;19(3):e0286933. pmid:38478473
   • 
     View Article
     
   • 
     PubMed/NCBI
     
   • 
     Google Scholar
     
8. 8.
   Yaden DB, Griffiths RR. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol Transl Sci. 2020;4(2):568–72. pmid:33861219
   • 
     View Article
     
   • 
     PubMed/NCBI
     
   • 
     Google Scholar
     
9. 9.
   Roseman L, Nutt DJ, Carhart-Harris RL. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol. 2018;8:974. pmid:29387009
   • 
     View Article
     
   • 
     PubMed/NCBI
     
   • 
     Google Scholar
     
10. 10.
    Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, mystical experience, and therapeutic efficacy: a systematic review. Front Psych. 2022;13.
    • 
      View Article
      
    • 
      Google Scholar
      
11. 11.
    Fincham GW, Kartar A, Uthaug MV, Anderson B, Hall L, Nagai Y, et al. High ventilation breathwork practices: an overview of their effects, mechanisms, and considerations for clinical applications. Neurosci Biobehav Rev. 2023;155:105453. pmid:37923236
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
12. 12.
    Fincham GW, Epel E, Colasanti A, Strauss C, Cavanagh K. Effects of brief remote high ventilation breathwork with retention on mental health and wellbeing: a randomised placebo-controlled trial. 2024.
13. 13.
    Franco Corso SJ, O’Malley KY, Subaiya S, Mayall D, Dakwar E. The role of non-ordinary states of consciousness occasioned by mind-body practices in mental health illness. J Affect Disord. 2023;335:166–76. pmid:37150220
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
14. 14.
    Bayley PJ, Schulz-Heik RJ, Tang JS, Mathersul DC, Avery T, Wong M. Randomised clinical non-inferiority trial of breathing-based meditation and cognitive processing therapy for symptoms of post-traumatic stress disorder in military veterans. BMJ Open. 2022;12(8).
    • 
      View Article
      
    • 
      Google Scholar
      
15. 15.
    Dittrich A. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry. 1998;31 Suppl 2:80–4. pmid:9754838
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
16. 16.
    Freud S. Civilization and its discontents. Dover ed. New York: Dover Publications; 1994.
17. 17.
    Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One. 2010;5(8):e12412. pmid:20824211
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
18. 18.
    Olbrich S, Preller KH, Vollenweider FX. LSD and ketanserin and their impact on the human autonomic nervous system. Psychophysiology. 2021;58(6):e13822. pmid:33772794
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
19. 19.
    Rosas FE, Mediano PAM, Timmermann C, Luppi AI, Candia-Rivera D, Abbasi-Asl R. The entropic heart: tracking the psychedelic state via heart rate dynamics. 2023.
20. 20.
    American Psychiatric A. Diagnostic and statistical manual of mental disorders. 2013.
21. 21.
    Qualtrics. Qualtrics. https://www.qualtrics.com.
22. 22.
    Watson D, Clark LA. The PANAS-X: Manual for the Positive and Negative Affect Schedule – Expanded Form. 1994; Available from: https://iro.uiowa.edu/esploro/outputs/other/The-PANAS-X-Manual-for-the-Positive/9983557488402771#file-0.
23. 23.
    Schruers K, Klaassen T, Pols H, Overbeek T, Deutz NE, Griez E. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res. 2000;93(3):179–87. pmid:10760376
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
24. 24.
    Griez EJ, Colasanti A, van Diest R, Salamon E, Schruers K. Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity. PLoS ONE. 2007;2(10).
    • 
      View Article
      
    • 
      Google Scholar
      
25. 25.
    Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70. pmid:3397865
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
26. 26.
    Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez‐Garcia L, et al. Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic Resonan Med. 2014;73(1):102–16.
    • 
      View Article
      
    • 
      Google Scholar
      
27. 27.
    Friston K, Ashburner J, Kiebel S, Nichols T, Penny W. Statistical parametric mapping. 2007.
28. 28.
    Parak J, Tarniceriu A, Renevey P, Bertschi M, Delgado-Gonzalo R, Korhonen I. Evaluation of the beat-to-beat detection accuracy of PulseOn wearable optical heart rate monitor. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:8099–102. pmid:26738173
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
29. 29.
    Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5.
    • 
      View Article
      
    • 
      Google Scholar
      
30. 30.
    Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, et al. The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. J Psychopharmacol. 2011;25(11):1562–7. pmid:20395317
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
31. 31.
    Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. Journal of Statistical Software. 2015;67(1):1–48.
    • 
      View Article
      
    • 
      Google Scholar
      
32. 32.
    Lenth R. Estimated marginal means, aka least-squares means. 2025.
33. 33.
    Tarvainen MP, Niskanen J-P, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV–heart rate variability analysis software. Comput Methods Programs Biomed. 2014;113(1):210–20. pmid:24054542
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
34. 34.
    Studerus E. Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness. University of Zurich; 2012.
35. 35.
    Mattson MP. Hormesis defined. Ageing Res Rev. 2008;7(1):1–7. pmid:18162444
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
36. 36.
    Pruimboom L, Muskiet FAJ. Intermittent living; the use of ancient challenges as a vaccine against the deleterious effects of modern life – a hypothesis. Med Hypotheses. 2018;120:28–42. pmid:30220336
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
37. 37.
    Hartogsohn I. Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. J Psychopharmacol. 2016;30(12):1259–67. pmid:27852960
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
38. 38.
    Roseman L, Nutt DJ, Carhart-Harris RL. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol. 2018;8.
    • 
      View Article
      
    • 
      Google Scholar
      
39. 39.
    Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL. Effects of DMT on mental health outcomes in healthy volunteers. Sci Rep. 2024;14(1):3097. pmid:38326357
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
40. 40.
    Uthaug MV, Lancelotta R, van Oorsouw K, Kuypers KPC, Mason N, Rak J. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology. 2019;236(9):2653–66.
    • 
      View Article
      
    • 
      Google Scholar
      
41. 41.
    Smigielski L, Scheidegger M, Kometer M, Vollenweider FX. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Neuroimage. 2019;196:207–15. pmid:30965131
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
42. 42.
    Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P, et al. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. 2022;47(6):1180–7. pmid:35217796
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
43. 43.
    Raichle ME, Plum F. Hyperventilation and cerebral blood flow. Stroke. 1972;3(5):566–75.
    • 
      View Article
      
    • 
      Google Scholar
      
44. 44.
    Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63. pmid:18042300
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
45. 45.
    Kartar AA, Colasanti A. Respiratory control and circuitry. In: Reference module in neuroscience and biobehavioral psychology. Elsevier; 2024.
46. 46.
    Betka S, Adler D, Similowski T, Blanke O. Breathing control, brain, and bodily self-consciousness: toward immersive digiceuticals to alleviate respiratory suffering. Biol Psychol. 2022;171:108329. pmid:35452780
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
47. 47.
    Sirigu A, Desmurget M. Somatosensory awareness in the parietal operculum. Brain. 2021;144(12):3558–60. pmid:34791060
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
48. 48.
    Felleman DJ, Van Essen DC. Distributed hierarchical processing in the primate cerebral cortex. Cereb Cortex. 1991;1(1):1–47. pmid:1822724
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
49. 49.
    Sepulcre J, Sabuncu MR, Yeo TB, Liu H, Johnson KA. Stepwise connectivity of the modal cortex reveals the multimodal organization of the human brain. J Neurosci. 2012;32(31):10649–61. pmid:22855814
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
50. 50.
    Gentile G, Guterstam A, Brozzoli C, Ehrsson HH. Disintegration of multisensory signals from the real hand reduces default limb self-attribution: an fMRI study. J Neurosci. 2013;33(33):13350–66. pmid:23946393
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
51. 51.
    Picard F. Ecstatic or mystical experience through epilepsy. J Cogn Neurosci. 2023;35(9):1372–81. pmid:37432752
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
52. 52.
    Picard F, Craig AD. Ecstatic epileptic seizures: a potential window on the neural basis for human self-awareness. Epilepsy Behav. 2009;16(3):539–46. pmid:19836310
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
53. 53.
    Craig ADB. How do you feel–now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10(1):59–70. pmid:19096369
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
54. 54.
    Picard F, Scavarda D, Bartolomei F. Induction of a sense of bliss by electrical stimulation of the anterior insula. Cortex. 2013;49(10):2935–7. pmid:24074887
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
55. 55.
    Sheikh MM, Koubeissi MZ, Spencer DD, Alkawadri R. The neural networks underlying the illusion of time dilation. Ann Neurol. 2022;91(2):295–7.
    • 
      View Article
      
    • 
      Google Scholar
      
56. 56.
    Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A. 2012;109(6):2138–43. pmid:22308440
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
57. 57.
    Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. Neuroimage. 2017;159:70–8. pmid:28711736
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
58. 58.
    Lewis-Healey E, Tagliazucchi E, Canales-Johnson A, Bekinschtein TA. Breathwork-induced psychedelic experiences modulate neural dynamics. Cerebral Cortex. 2024;34(8).
    • 
      View Article
      
    • 
      Google Scholar
      
59. 59.
    Phelps EA. Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol. 2004;14(2):198–202. pmid:15082325
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
60. 60.
    Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology. 2018;142:263–9.
    • 
      View Article
      
    • 
      Google Scholar
      
61. 61.
    Nutt D, Erritzoe D, Carhart-Harris R. Psychedelic psychiatry’s brave new world. Cell. 2020;181(1):24–8. pmid:32243793
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
62. 62.
    Healy CJ. The acute effects of classic psychedelics on memory in humans. Psychopharmacology (Berl). 2021;238(3):639–53. pmid:33420592
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
63. 63.
    Seppälä EM, Nitschke JB, Tudorascu DL, Hayes A, Goldstein MR, Nguyen DTH, et al. Breathing-based meditation decreases posttraumatic stress disorder symptoms in U.S. military veterans: a randomized controlled longitudinal study. J Trauma Stress. 2014;27(4):397–405. pmid:25158633
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
64. 64.
    Steventon JJ, Foster C, Furby H, Helme D, Wise RG, Murphy K. Hippocampal blood flow is increased after 20 min of moderate-intensity exercise. Cerebral Cortex. 2019;30(2):525–33.
    • 
      View Article
      
    • 
      Google Scholar
      
65. 65.
    Kety SS, Schmidt CF. Measurement of cerebral blood flow and cerebral oxygen consumption in man. Fed Proc. 1946;5:264. pmid:21064908
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
66. 66.
    Fincham GW, Kartar A, Uthaug MV, Anderson B, Hall L, Nagai Y, et al. High ventilation breathwork practices: an overview of their effects, mechanisms, and considerations for clinical applications. Neurosci Biobehav Rev. 2023;155:105453. pmid:37923236
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
67. 67.
    Schüttler D, von Stülpnagel L, Rizas KD, Bauer A, Brunner S, Hamm W. Effect of hyperventilation on periodic repolarization dynamics. Front Physiol. 2020;11.
    • 
      View Article
      
    • 
      Google Scholar
      
68. 68.
    Oswald V, Vanhaudenhuyse A, Annen J, Martial C, Bicego A, Rousseaux F. Autonomic nervous system modulation during self-induced non-ordinary states of consciousness. Scient Rep. 2023;13(1).
    • 
      View Article
      
    • 
      Google Scholar
      
69. 69.
    dos Santos RG, Valle M, Bouso JC, Nomdedéu JF, Rodríguez-Espinosa J, McIlhenny EH. Autonomic, neuroendocrine, and immunological effects of Ayahuasca. J Clin Psychopharmacol. 2011;31(6):717–26.
    • 
      View Article
      
    • 
      Google Scholar
      
70. 70.
    Liechti ME, Dolder PC, Schmid Y. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacol (Berl). 2017;234(9–10):1499–510. pmid:27714429
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
71. 71.
    Sparber SB, Dwoskin LP, Kleven MS. Studies on the specificity of neurochemical and behavioral effects of LSD-25. Pharmacol Biochem Behav. 1986;24(2):341–5.
    • 
      View Article
      
    • 
      Google Scholar
      
72. 72.
    Bonnelle V, Feilding A, Rosas FE, Nutt DJ, Carhart-Harris RL, Timmermann C. Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in wellbeing. bioRxiv. 2024.
    • 
      View Article
      
    • 
      Google Scholar
      
73. 73.
    Strassman RJ. Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res. 1996;73(1–2):121–4. pmid:8788488
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
74. 74.
    Crosswell AD, Mayer SE, Whitehurst LN, Picard M, Zebarjadian S, Epel ES. Deep rest: an integrative model of how contemplative practices combat stress and enhance the body’s restorative capacity. Psychol Rev. 2024;131(1):247–70. pmid:38147050
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar
      
75. 75.
    Canello T, Tlaie A, Chalise K, Schölvinck ML, Pia L, Havenith MN. Non-ordinary states of consciousness evoked by breathwork correlate with improved heart-rate variability. 2024.
76. 76.
    Wu W-C, Edlow BL, Elliot MA, Wang J, Detre JA. Physiological modulations in arterial spin labeling perfusion magnetic resonance imaging. IEEE Trans Med Imaging. 2009;28(5):703–9. pmid:19150788
    • 
      View Article
      
    • 
      PubMed/NCBI
      
    • 
      Google Scholar